04.03.2010 • NewsLyondellBasellReliance

Reliance Not Planning to up Lyondell Offer

India's Reliance Industries does not plan to raise its bid for bankrupt petrochemicals maker LyondellBasell, a source familiar with the matter said on Wednesday. Shares in Reliance were boosted on Wednesday as investor fears the Indian energy major would overpay for LyondellBasell were allayed after the Luxembourg-headquartered group was said to have rejected its offer, which valued the target at about $14.5 billion.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.